Based on the headline and public reporting, the article covers a rare joint push by Sam Altman, Dario Amodei, Demis Hassabis, and other AI leaders for US biosecurity legislation. They are asking lawmakers to require synthetic DNA and RNA providers to screen customers, orders, and records. The concern is that advanced AI could lower the knowledge barrier for designing dangerous biological agents.
Google DeepMind has announced a major breakthrough by its AI scientific assistant "Co-Scientist" in the biomedical field. Biologists using the system have…
One of the greatest challenges in biomedical and anti-aging research is finding meaningful connections within the vast, fragmented, and interdisciplinary body…
This latest case study from Google DeepMind details how AI is playing a pivotal role in the biomedical field. Professor Filippo Menolascina of the University…
Google DeepMind has recently announced a major biomedical collaboration milestone, revealing that its AI scientific research system "Co-Scientist" is playing a…
As global temperatures continue to rise, extreme weather events and heat waves are posing a severe threat to agricultural production and food security…
Google DeepMind recently announced that AlphaFold, its revolutionary protein structure prediction tool, has achieved a major breakthrough in medicine by…
This article from the Hugging Face blog provides a detailed introduction to accelerating the advanced protein language model ProtST on Intel Gaudi 2 deep…